Prominent IP Updates on Dec 19, 2014

Authors : Rishabh Manocha, Akanksha Anand

EU’s top court opens door to some stem cell patents

(Reuters) – Europe’s top court has opened the door to certain stem cell patents in the European Union by ruling that an organism incapable of developing into a human being is not a human embryo and may be patented.

Patent request shows Touch ID could learn a few new unlock tricks

The Touch ID fingerprint sensor already securely unlocks iPhones and iPads. Can it be any more secure though? Yes, based on a patent application submitted by Apple in June, 2013 it describes that the Touch ID authentication could be paired with an on-screen UI as a method of unlocking to further enhance device security. Based on the description, the sensor could support a combination of your fingerprint in addition to a pattern swipe unlock process

Uber Seeks to Patent Pricing Surges That Critics Call Gouging

Uber applied for a U.S. patent last year for “dynamically adjusting prices for service” using mobile devices. The system measures supply (Uber drivers) and demand (passengers hailing rides with smartphones), and prices fares accordingly.

Read More:

ParkerVision (PRKR) Receives Mixed Decision in Patent Case

ParkerVision (NASDAQ: PRKR) announced that the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) denied institution of trial for inter partes review (“IPR”) of one claim contained in three ParkerVision patents and granted trial for 14 claims contained in those same three patents.

Read More:

Researchers hope patent can pave way to future treatments of heart, lung disease

A Kansas State University research team has received a patent for its use of a peptide that has been shown to prevent or reduce damage to intestinal tissue. The team’s ongoing work may have far-reaching implications, including new ways to treat tissue damaged during a heart attack or stroke, and even a possible cure for cancer.

Prominent IP Updates on Dec 19, 2014

Authors : Rishabh Manocha, Akanksha Anand

EU’s top court opens door to some stem cell patents

(Reuters) – Europe’s top court has opened the door to certain stem cell patents in the European Union by ruling that an organism incapable of developing into a human being is not a human embryo and may be patented.

Patent request shows Touch ID could learn a few new unlock tricks

The Touch ID fingerprint sensor already securely unlocks iPhones and iPads. Can it be any more secure though? Yes, based on a patent application submitted by Apple in June, 2013 it describes that the Touch ID authentication could be paired with an on-screen UI as a method of unlocking to further enhance device security. Based on the description, the sensor could support a combination of your fingerprint in addition to a pattern swipe unlock process

Uber Seeks to Patent Pricing Surges That Critics Call Gouging

Uber applied for a U.S. patent last year for “dynamically adjusting prices for service” using mobile devices. The system measures supply (Uber drivers) and demand (passengers hailing rides with smartphones), and prices fares accordingly.

Read More:

ParkerVision (PRKR) Receives Mixed Decision in Patent Case

ParkerVision (NASDAQ: PRKR) announced that the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) denied institution of trial for inter partes review (“IPR”) of one claim contained in three ParkerVision patents and granted trial for 14 claims contained in those same three patents.

Read More:

Researchers hope patent can pave way to future treatments of heart, lung disease

A Kansas State University research team has received a patent for its use of a peptide that has been shown to prevent or reduce damage to intestinal tissue. The team’s ongoing work may have far-reaching implications, including new ways to treat tissue damaged during a heart attack or stroke, and even a possible cure for cancer.

Prominent IP Updates on Dec 19, 2014

Authors : Rishabh Manocha, Akanksha Anand

EU’s top court opens door to some stem cell patents

(Reuters) – Europe’s top court has opened the door to certain stem cell patents in the European Union by ruling that an organism incapable of developing into a human being is not a human embryo and may be patented.

Patent request shows Touch ID could learn a few new unlock tricks

The Touch ID fingerprint sensor already securely unlocks iPhones and iPads. Can it be any more secure though? Yes, based on a patent application submitted by Apple in June, 2013 it describes that the Touch ID authentication could be paired with an on-screen UI as a method of unlocking to further enhance device security. Based on the description, the sensor could support a combination of your fingerprint in addition to a pattern swipe unlock process

Uber Seeks to Patent Pricing Surges That Critics Call Gouging

Uber applied for a U.S. patent last year for “dynamically adjusting prices for service” using mobile devices. The system measures supply (Uber drivers) and demand (passengers hailing rides with smartphones), and prices fares accordingly.

Read More:

ParkerVision (PRKR) Receives Mixed Decision in Patent Case

ParkerVision (NASDAQ: PRKR) announced that the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) denied institution of trial for inter partes review (“IPR”) of one claim contained in three ParkerVision patents and granted trial for 14 claims contained in those same three patents.

Read More:

Researchers hope patent can pave way to future treatments of heart, lung disease

A Kansas State University research team has received a patent for its use of a peptide that has been shown to prevent or reduce damage to intestinal tissue. The team’s ongoing work may have far-reaching implications, including new ways to treat tissue damaged during a heart attack or stroke, and even a possible cure for cancer.

DISCLAIMER

The Bar Council of India does not permit the solicitation of work and advertising by legal practitioners and advocates.
This website has been designed only for the purposes of dissemination of basic information on KAnalysis; information that is otherwise available on the internet, various public platforms and social media. Careful attention has been given to ensure that the information provided herein is accurate and up-to-date. However, KAnalysis is not responsible for any reliance that a reader places on such information and shall not be liable for any loss or damage caused due to any inaccuracy in or exclusion of any information, or its interpretation thereof. The reader is advised to confirm the veracity of the same from independent and expert sources.
This website is not an attempt to advertise or solicit clients and does not seek to create or invite any lawyer-client relationship. The links provided on this website are to facilitate access to basic information on KAnalysis, and, to share the various thought leadership initiatives undertaken by it. The content herein or on such links should not be construed as a legal reference or legal advice. Readers are advised not to act on any information contained herein or on the links and should refer to legal counsels and experts in their respective jurisdictions for further information and to determine its impact.
KAnalysis advises against the use of the communication platform provided on this website for the exchange of any confidential, business or politically sensitive information. User is requested to use his or her judgment and exchange of any such information shall be solely at the user’s risk.
KAnalysis uses cookies on its website to improve its usability. This helps us in providing a good user experience and also helps in improving our website. By continuing to use our website without changing your privacy settings, you agree to use our cookies.
Terms of use and Privacy policy